Mizuho Securities Reiterates Buy Rating on Gilead Sciences (GILD) Following Sell-Side Management Open House

January 13, 2022 5:02 PM EST Send to a Friend
Mizuho Securities analyst Salim Syed reiterated a Buy rating and $81.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login